Schedule 13G ownership disclosure

N/A

Common Stock, par value $0.001 per share · CUSIP: 09627Y109

Event date: 2025-07-14

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • M.H. Davidson & Co.

    Shares: 0.00 · Class: 0%

  • Davidson Kempner Arbitrage, Equities and Relative Value LP

    Shares: 0.00 · Class: 0%

  • Davidson Kempner Capital Management LP

    Shares: 0.00 · Class: 0%

  • Anthony A. Yoseloff

    Shares: 0.00 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-25-003076
Form type
SCHEDULE 13G
Filer
Blueprint Medicines Corp
CIK
CIK 1597264
Filed
Jul 21, 2025
Reporting period
Jul 14, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub